10 June 2011, the following letter was sent to various members of the UK Parliament’s Health Committee:

Subject: HPV Vaccines Cervarix and Gardasil – for the attention of the Health Committee

For the attention of the Health Committee

Dear Members

I would appreciate it if consideration could be given to the undernoted points relating to the HPV vaccination programme in the UK.

The first paper above was prepared by myself as I had been asked a question by a politician ‘would I be happy if Cervarix was removed from the market’? I replied to this above but also answered the question I was not asked ‘would I be happy if Gardasil replaced Cervarix as the main HPV vaccine in the UK’? I believe the above provides information on both of these vaccines but more importantly on the HPV Gardasil. There has been a lot of speculation in the press of late that consideration is being given to replacing Cervarix with Gardasil in the UK and I wish to draw your attention to the dangers of Gardasil. The information I have provided has been taken from the VAERS Reporting System (Vaccine Adverse Events Reporting System). Please note as of April 2011, 96 deaths have been reported following vaccination, including 2 boys and 21,984 serious adverse effects. It is recognised that this represents only between 1% and 10% of those victims who file reports to VAERS, therefore the true figures could be astronomical. Young healthy girls/women have died suddenly after vaccination with Gardasil and in some cases their cause of death cannot be determined. We hear every week from mothers whose daughters were ill but who did not associate their illnesses with the vaccination until they realised that their daughters’ symptoms were being experienced by so many others. This is a common occurrence.

The second paper above was prepared by my colleague Grace Filby, BA(Hons), Cert Ed, FRSA – retired deputy Head Teacher. Grace had been making enquiries of the MHRA regarding the length of time girls are ill after vaccination with Cervarix. The MHRA reply was that in their opinion side effects lasted only between 7-10 days. The above paper proves that this information is incorrect. The MHRA reference numbers are identified and this information was obtained from the VAERS reporting system on Cervarix. All of this can be easily checked out per the reference numbers and it will show that there are UK girls who are having more serious side effects which are lasting a longer period of time than is being reported by the MHRA. When you read some of the symptoms in this report you will find that many of them are recognised side effects of this vaccine. The existing MHRA database does not provide any information or reports on the experiences of girls after vaccination with Cervarix. Perhaps for the benefit of the Health Committee, it might be more helpful if you could see in the future what information is actually reported which would give you more of an idea of how the vaccine programme is progressing. At the moment all you get from the MHRA are symptoms and numbers. If there is nothing to hide then there should not be a problem of providing you with fuller reports.

Questions I would wish to raise:

1. Just how safe is aluminium? Aluminium is a recognised neurotoxin and is used as an adjuvant in the vaccine. It has been related to the “Gulf War Syndrome” and a team of scientists also found that vaccination involving aluminium-containing adjuvant could trigger the cascade of immunological events that are associated with autoimmune conditions, including chronic fatigue syndrome and macrophagic myofasciitis, a condition that causes profound weakness and multiple neurological syndromes, one of which closely resembles multiple sclerosis.

2. If HPV strains 16 and 18 are eradicated then is there not a possibility of other HPV cancer related strains becoming more dominant and more virulent? Nature does not normally like a void. If this should occur then this programme will have been wasted. If the vaccine takes out two or three HPV strains, it will give competitive advantage to the rest of them to take over. The same applies with bacteria and antibiotics and there is sufficient evidence of that. Until girls go for their Pap screening then this will not be known but was this possibility ever considered in the first place?

3. Should there not be some screening before vaccination to determine those who are already infected with strains 16 & 18 HPV? If girls are infected with either or both strains then they will not be fully protected or will be unprotected. It has been reported that since the programme of vaccination commenced there has been a rise in the cases of chlamydia in Scottish school girls.

4. Should participants of the HPV programme be informed of all negative aspects as well as the positive aspects of the vaccination programme and should this not take place at time of consent when discussions can take place with their parents?

5. Is sufficient care taken with girls with a history of allergic reactions, serious health issues and on medication prior to vaccination? Cervarix can cause allergic reactions and no trials were carried out to see if there would be a reaction with any types of medication?

6. Are girls sufficiently informed that if they experience an adverse reaction that it should be reported to the Yellow Card System and how many days after vaccination would it be regarded as being caused by the vaccine?

As it has not yet been proved that these vaccines will prevent cervical cancer, we may have to wait up to 30 years to find this out then the responsibility has to rest with those who introduced this programme of vaccination and take on board questions which are relevant as the safety of our school girls is of paramount importance. I hope you will give some time to consider the points I have made above and I thank you in advance. I know girls who have been harmed by both the HPV vaccines and sadly families of girls who have died after Gardasil and therefore that is why I ask for help for there to be more of an investigation into these two vaccines. The information I have provided is all genuine and can be checked out by yourselves – I just believe you are not being given all of the facts and hope that the above provides you with information you were not aware of before. The Cervarix programme covers all girls within the UK.

Yours sincerely

Mrs Freda Birrell – East Lothian

Read the response from the Health Department, dated 07 July 2011, here.

26 July 2011, Mrs. Birrell sent the following letter in reply to the Health Minister’s letter:

Dear Minister

My note refers again to your letter of 7th July 2011 and to the fifth paragraph on the first page and I quote:

“There is a possibility that other HPV strains could replace HPV-16 and –18 following the introduction of the HPV vaccination programme. However, there is no data with which to determine whether and how quickly this would take place. The vaccination programme targets the two HPV types that are known to cause the vast majority of cervical cancer to protect the women vaccinated from these established causes of cervical cancer. The Health Protection Agency is carrying out surveillance of HPV types in the population following the introduction of the vaccination campaign to assess the impact of the programme. Women are still encouraged to go for cervical screening when invited.”

I am very concerned by the first two sentences you make above. To start such a crucial and important vaccination programme without taking all the necessary steps to ensure its complete safety is astonishing. I am aware that the Conservatives were not in power when the decisions were made to introduce this vaccination programme to our schools in September 2008. With the history of germs and viruses mutating in the UK, in our hospitals because of mismanagement, overuse, insufficient research having been carried out to determine what effects certain medications/vaccinations would have in the long term, I would have thought greater care would have been taken with a vaccine that only covers two out of the many serious HPV strains which are present at this time – they cover 70% which in itself leaves 30% still vulnerable. It may well be that the two strains targeted, HPV 16 and 18, are the most serious but as our own history dictates that does not mean that others will not become more dominant and more virulent and take over from them if they should be weakened or eliminated. However, for no monitoring to have been carried out prior to this becoming an established programme is quite alarming.

Please see the two letters above, one to Dr Lauri Markowitz, CDC and to Mark Schiffman, Senior Investigator, Maryland. Within these letters, among many other points, is the undernoted which is significant and it would be interesting to know if we have this very advanced form of DNA sequencing available in the UK?

“Based on the VAERS Reports, a significant number of post-vaccinated women are now developing cervical pre-cancer and cancer lesions. It is extremely important for the public to be informed if these cervical pre-cancer or cancer lesions are being caused by vaccine-relevant HPV genotypes or by HPV genotypes not targeted by the HPV vaccines. Since both the FDA [3] and the NCI [4] have acknowledged that the only reliable HPV genotyping is by DNA sequencing, the consumers who have paid a great price for this controversial vaccine want to have post-licensure monitoring data based on HPV genotype determination by DNA sequencing.”

Only by monitoring what happens after vaccination will you be able to determine if the programmes, including both Gardasil and Cervarix, are actually working or if the two strains 16 and 18 are found to be present in some of the subjects, meaning the vaccines have not worked; or other relevant strains are present in the subjects which the vaccines do not cover. Until precise monitoring of data based on HPV genotype determination by DNA sequencing is carried out then you are not going to have any idea what the future holds for all the girls in the UK who have been vaccinated, either with Cervarix or Gardasil. I note you mention that the HPA is carrying out a surveillance of HPV types within the population since this vaccination programme was introduced into the UK. Does that include the young girls aged 12 to 14 who have been vaccinated?; or include the older girls up to the age of 18? We have to bear in mind that Pap screening only begins in Scotland at the age of 20 and in England and Wales at the age of 25.

Therefore, if there has not been, and there is no intention to have, careful monitoring within these younger age groups, then many years will pass before you will have any idea if this programme has been successful or not or if many of these young people have been adversely affected as is now occurring in the States. This could well be a disaster waiting to happen and in your own words ‘you are not in possession of any data to confirm one way or another if other strains are becoming more virulent or if strains HPV 16 and 18 are being eradicated’. Many, many years will have to pass before you will know the answers to this.

Just as an afterthought, because the girls are young does not mean they may not have been infected with HPV prior to vaccination; there is a lot of research carried out by Dr John Cason, King’s College, London whereby he proved that young children can be infected without there having to be any sexual contact. Also another relevant factor and one which also is proven is that there are more cases of Chlamydia in young girls in Scotland (the ages of those being vaccinated) since Cervarix was introduced on to the market. Therefore, many within the relevant age groups are sexually active and sadly it appears they believe the vaccine will protect them from other STD’s which is most definitely not the case. There has been very poor education of the facts.

I now refer you to the reports which are starting to come into the VAERS (Vaccine Adverse Events Reporting System) where the undernoted has been reported. Please remember that these reports cover girls who have been vaccinated with Gardasil and these results are appearing after vaccination has been completed. These numbers represent only between 1% and 10% of affected girls or medical personnel reporting adverse events after vaccination with the HPV vaccine Gardasil. The Gardasil programme started in America in June 2006 – there have to be answers why over a period of five years many of those who were vaccinated are now having the problems that the vaccine was supposed to prevent. This is what I do not wish to see occurring in the UK.

Abnormal Pap Smear 378

Cervical Dysplasia 135

Cervical Cancer cases diagnosed 41 Total = 554

I refer you to our history of overuse of antibiotics and the health conditions which exist with MRSA:

Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium responsible for several difficult-to-treat infections in humans. It may also be called multidrug-resistant Staphylococcus aureus or oxacillin-resistant Staphylococcus aureus (ORSA).

The recent information regarding the dangerous mutation of Gonorrhea

Gonorrhea Dangerous mutation: a disease that had a cure

Posted by Kelley Jeanie On Saturday, July 16th 2011 in News

Gonorrhea is a sexual disease that had a cure if the treatment was based on an antibiotic, but the scientists found that the disease had a dangerous mutation that is very resistant on the cure with antibiotics.

More, the scientist warns that the sexual transmission disease might become a global health problem, especially in this moment when in Japan there was discovered a case of gonorrhea, having the mutation H041, that is incurable. Gonorrhea disease evolved in the last years and all the treatment became one by one inefficient.

These are just two examples of many such incidents which are occurring and which I am sure you will agree are totally alarming. Please consider these points which have been made and realise that I am not just trying to downgrade the vaccination programme but sadly to highlight that insufficient safety measures appear to have been put in place. Can you guarantee that our young girls will not be faced with abnormal Pap smears, Cervical Dysplasia or cases of Cervical Cancer once they are old enough to be screened? Only by being able to give this guarantee will we know that the programme is safe. However, in your own words you honestly cannot do that with the population who have been vaccinated over these last two years and more as there is no data available to determine what is actually going on inside their bodies.

With best wishes

Yours sincerely

Mrs Freda Birrell